Evidence map›Paper›PMID 36613097›Full record

SynthesisInternational journal of environmental research and public health2022

The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials.

Mathilda Skeie-Larsen, Rebekka Stave, Janne Grønli, Bjørn Bjorvatn, Ane Wilhelmsen-Langeland, Amin Zandi, Ståle Pallesen

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Neurogenetics and Epigenetics of Loneliness.Psychology research and behavior management · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mathilda Skeie-LarsenDepartment of Psychosocial Science, University of Bergen, 5007 Bergen, Norway.
Rebekka StaveDepartment of Psychosocial Science, University of Bergen, 5007 Bergen, Norway.
Janne GrønliDepartment of Biological and Medial Psychology, University of Bergen, 5007 Bergen, Norway.
Bjørn BjorvatnNorwegian Competence Center for Sleep Disorders, Haukeland University Hospital, 5021 Bergen, Norway.ORCID 0000-0001-7051-745X
Ane Wilhelmsen-LangelandBjørgvin District Psychiatric Center, Division of Psychiatry, Haukeland University Hospital, 5021 Bergen, Norway.
Amin ZandiFaculty of Psychology and Educational Sciences, University of Tehran, Tehran 1417935840, Iran.ORCID 0000-0001-9493-1313
Ståle PallesenDepartment of Psychosocial Science, University of Bergen, 5007 Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nightmares are highly prevalent and distressing for the sufferer, which underlines the need for well-documented treatments. A comprehensive literature review and meta-analysis of the effects of different pharmacological placebo-controlled randomized clinical trials, covering the period up to 1 December 2022, was performed. Searches were conducted in PubMed, Embase, Web of Science, PsychInfo, Cinahl, and Google Scholar, resulting in the identification of 1762 articles, of which 14 met the inclusion criteria: pharmacological intervention of nightmares, based on a placebo-controlled randomized trial published in a European language, reporting outcomes either/or in terms of nightmare frequency, nightmare distress, or nightmare intensity, and reporting sufficient information enabling calculation of effect sizes. Most studies involved the effect of the α

Indexed as

DreamsStress Disorders, Post-TraumaticAdrenergic alpha-1 Receptor AntagonistsDronabinolHumansHydroxyzinePrazosinRandomized Controlled Trials as TopicAdrenergic alpha-1 Receptor AntagonistsDronabinolHydroxyzinenabilonePrazosinmeta-analysisnightmarepharmacological interventionPTSDRCT

Identifiers

PMID36613097
PMCPMC9820008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.